1-3 of 3
Tim Bruemmendorf, MD
Close
Sort by
Journal Articles

Synergistic Induction of Cell Death and Apoptosis by the Histone Deacetylase Inhibitor SAHA (Vorinostat) and the Demethylating Agent DAC in Multiple Myeloma.

Edgar Jost, Claudia Schubert, Tim Bruemmendorf, MD, Oliver Galm
Journal: Blood
Blood (2009) 114 (22): 2393.
https://doi.org/10.1182/blood.V114.22.2393.2393
Published: 2009
Journal Articles

The Effects of Induction Chemotherapy and High-Dose Melphalan with Tandem Autologous Transplantation in Multiple Myeloma: The Prospective Randomized DSMM 2 Study.

Christian Straka, MD, PhD, Peter Liebisch, MD, Burkhard Hennemann, MD, Bernd Metzner, MD, Hans Salwender, MD, Lothar Kanz, MD, PhD, Sigrid Adler-Reichel, MD, Wolf-Dieter Ludwig, MD, PhD, Hannes Wandt, MD, PhD, Martin Bentz, MD, PhD, Tim Bruemmendorf, MD, PhD, Markus Hentrich, MD, Lorenz Truemper, MD, PhD, Mathias Freund, MD, PhD, Hans-Heinrich Wolf, MD, Sezer Orhan, MD, PhD, Ralf Bargou, MD, PhD, Gottfried Doelken, MD, PhD, Norbert Schmitz, MD, PhD, Helga Bernhard, MD, PhD, Martin Gramatzki, MD, PhD, Norbert Frickhofen, MD, PhD, Helmut Ostermann, MD, PhD, Ralf Schmidmaier, MD, Stefan Ibach, PhD, Axel Hinke, PhD, Hermann Einsele, MD, PhD, Bertold Emmerich, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 446.
https://doi.org/10.1182/blood.V110.11.446.446
Published: 2007
Journal Articles

Inhibition of Hypusination of Eukaryotic Initiation Factor 5a (eIF-5A) as a Novel a Synergistic Treatment Strategy in Imatinib-Treated BCR-ABL Positive Leukemias Identified by a Global Proteomics Approach.

Stefan Balabanov, MD, PhD, Patrick Ziegler, PhD, Ulricke Hartmann, Winfried Kammer, PhD, Mhairi Copland, MD, Martin Priemer, Thomas Wilhelm, Carsten Bokemeyer, MD, Lothar Kanz, MD, Tessa Holyoake, MD, Alfred Nordheim, PhD, Tim Bruemmendorf, MD
Journal: Blood
Blood (2005) 106 (11): 1997.
https://doi.org/10.1182/blood.V106.11.1997.1997
Published: 2005